Fig. 8: LukS-PV targets C5aR to inhibit EMT in HCC via the BCL6/HDAC6/HSPD1 axis.
From: LukS-PV targeting C5aR inhibits EMT in hepatocellular carcinoma via the BCL6/HDAC6/HSPD1 axis
a C5aR, BCL6, HDAC6, HSPD1, and acetylated HSPD1 levels were determined in 23 pairs of fresh HCC tissues and their corresponding adjacent non-tumor tissues. b Quantification data of (a) were expressed as mean ± SD (n = 23). c Schematic diagram of LukS-PV inhibits HCC metastasis in this research (By Figdraw). Statistical analysis was conducted using paired t-test. **, p < 0.01; ***, p < 0.001; ****, p < 0.0001; ns not significant.
